$ABTI
ALTEROLA BIOTECH INC. Stock $abti

2021 Q4 Form 10-Q Financial Statement

Concept	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.11K
YoY Change
Cash & Equivalents	$40.11K	$519.00
Short-Term Investments
Other Short-Term Assets	$14.79K	$12.77K
YoY Change	-26.05%	-36.15%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$90.71K	$12.77K
YoY Change	353.55%	-36.15%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$12.00M	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$90.71K	$12.77K
Total Long-Term Assets	$12.00M	$0.00
Total Assets	$12.09M	$12.77K
YoY Change	60353.55%	-36.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$574.7K
YoY Change
Accrued Expenses	$541.8K	$350.2K
YoY Change	46.42%	25.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.218M	$402.5K
YoY Change	229.14%	43.75%
LONG-TERM LIABILITIES
Long-Term Debt	$169.0K	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$169.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.218M	$402.5K
Total Long-Term Liabilities	$169.0K	$0.00
Total Liabilities	$1.387M	$402.5K
YoY Change	274.82%	43.75%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.70M	$136.00
YoY Change
Total Liabilities & Shareholders Equity	$12.09M	$12.77K
YoY Change	60353.55%	-36.15%

Concept	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$2.801M	-$247.5K
YoY Change	4567.8%	725.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$2.487M	-$50.00K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$12.00M
YoY Change
Cash From Investing Activities	-$11.97M	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	14.30M	50.00K
YoY Change
NET CHANGE
Cash From Operating Activities	-2.487M	-50.00K
Cash From Investing Activities	-11.97M	0.000
Cash From Financing Activities	14.30M	50.00K
Net Change In Cash	-148.2K	0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$2.487M	-$50.00K
Capital Expenditures		$0.00
Free Cash Flow		-$50.00K
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Profit Loss ProfitLoss	-4712691	USD
CY2021Q1	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset		USD
CY2021Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable		USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		USD
CY2021Q1	us-gaap	Intangible Assets Current IntangibleAssetsCurrent		USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		USD
CY2021Q4	us-gaap	Revenues Revenues		USD
	us-gaap	Revenues Revenues		USD
CY2021Q4	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		USD
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		USD
	us-gaap	Interest Paid InterestPaid		USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD